Skip to content

Home
Our approach to CDI
Solutions
Patient Interviews
Investor Slide deck
Contact Us

Home
Our approach to CDI
Solutions
Patient Interviews
Investor Slide deck
Contact Us

Contact Us

941-221-2505

[email protected]

ImmuniMed Inc., is a clinical-stage Biopharmaceutical Company focused on developing novel Oral Dose Preventive and Therapeutic Antibodies for unmet medical needs.

Copyright © 2025 ImmuniMed Inc. | All rights reserved

Scroll to Top